Cefepime + Tazobactum in pharma franchise in Maharashtra

Cefepime + Tazobactum in PCD pharma franchise in Chandigarh

Cefepime + Tazobactum in top pharma company in Shillong

Cefepime + Tazobactum in pcd pharma supplier in Madurai

Cefepime + Tazobactum in phama franchise company in India
Cefepime + Tazobactum in phama distributor in Siliguri

Home/Products /cefepime-1000mg-tazobactum-125mg-injection

About the Product

Description


Tillpime TZ Injection combines cefepime and tazobactam, offering a powerful therapeutic option for treating a variety of serious bacterial infections. Cefepime, a fourth-generation cephalosporin antibiotic, exhibits broad-spectrum activity against both Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. Tazobactam, a beta-lactamase inhibitor, enhances the efficacy of cefepime by preventing the breakdown of the antibiotic by resistant bacterial enzymes, thereby extending its spectrum of activity against resistant strains.

This formulation is particularly effective in treating conditions such as pneumonia, urinary tract infections, skin infections, and intra-abdominal infections caused by susceptible organisms. Due to its ability to penetrate well into tissues, Tillpime TZ is also utilized in the management of febrile neutropenia and other severe infections where rapid therapeutic intervention is critical.

Common side effects may include diarrhea, rash, nausea, headache, and potential allergic reactions. Serious side effects can occur, and patients should be monitored for signs of anaphylaxis or superinfection.

Tillpime TZ is indicated for the treatment of moderate to severe bacterial infections, including pneumonia, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections.

Use under medical supervision only; not recommended for patients with a known allergy to cephalosporins or beta-lactams. Always consult a healthcare professional before administration. Tillpime TZ Injection is administered intravenously, and dosing should be tailored to the individual patient's needs, taking into account the severity of the infection and renal function. Regular monitoring during treatment is essential to ensure therapeutic efficacy and to mitigate potential adverse effects. Always adhere to the recommended dosage guidelines to optimize treatment outcomes.

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Cefepime 1000mg + Tazobactam 125mg Injection in the PCD pharma franchise market?

Cefepime 1000mg + Tazobactam 125mg Injection has strong demand in the critical care and hospital antibiotic segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.

Why should medical distributors include Cefepime 1000mg + Tazobactam 125mg Injection in their product range?

Medical distributors and wholesalers can benefit from the high requirement of this combination in severe and resistant bacterial infections. Including this product helps strengthen their critical care and injectable antibiotic portfolio.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for Cefepime 1000mg + Tazobactam 125mg Injection?

Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Cefepime 1000mg + Tazobactam 125mg Injection with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for Cefepime 1000mg + Tazobactam 125mg Injection distribution?

Wholesalers and medical agencies benefit from attractive business margins, timely product availability, professional marketing support, and access to a trusted advanced injectable antibiotic range when partnering with Cafoli Lifecare for this combination injection.

How can I become a distributor or franchise partner for Cefepime 1000mg + Tazobactam 125mg Injection?

Medical distributors, stockists, wholesalers, and pharma professionals interested in Cefepime 1000mg + Tazobactam 125mg Injection can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.